Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0KV1Q
|
||||
Former ID |
DCL001020
|
||||
Drug Name |
Trafermin
|
||||
Synonyms |
Fiblast; Fiblast (TN); Trafermin (genetical recombination); Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
|
||||
Indication | Periodontitis [ICD9: 523.5; ICD10:K05.4] | Phase 3 | [536297] | ||
Company |
Johnson & Johnson Licensee; Kaken Pharmaceutical
|
||||
CAS Number |
CAS 131094-16-1
|
||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Fibroblast growth factor receptor 2 | Target Info | Activator | [536297] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
PANTHER Pathway | FGF signaling pathway | ||||
Pathway Interaction Database | FGF signaling pathway | ||||
Reactome | Activated point mutants of FGFR2 | ||||
WikiPathways | Regulation of Actin Cytoskeleton | ||||
Ectoderm Differentiation | |||||
Hair Follicle Development: Organogenesis (Part 2 of 3) | |||||
Hair Follicle Development: Induction (Part 1 of 3) | |||||
Cardiac Hypertrophic Response | |||||
Signaling Pathways in Glioblastoma | |||||
Neural Crest Differentiation | |||||
Signaling by FGFR | |||||
MicroRNAs in cardiomyocyte hypertrophy | |||||
Angiogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.